We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$150M
AUM Growth
+$5.06M
Cap. Flow
+$627K
Cap. Flow %
0.42%
Top 10 Hldgs %
78.75%
Holding
50
New
10
Increased
7
Reduced
5
Closed
11

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$10.2M
2
BX icon
Blackstone
BX
+$7.53M
3
AMZN icon
Amazon
AMZN
+$5.49M
4
QLTI
QLT Inc
QLTI
+$3.28M
5
AKRX
Akorn Inc
AKRX
+$1.58M

Sector Composition

Rank Sector Weight
1 Healthcare 62.32%
2 Financials 11.64%
3 Consumer Discretionary 11.16%
4 Technology 6.86%
5 Communication Services 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADVM
26
DELISTED
Adverum Biotechnologies
ADVM
$519K 0.35%
17,865
-1,127
-6% -$36.8K
VTRS icon
27
Viatris
VTRS
$20.8B
$382K 0.25%
+10,000
New +$372K
GRPN icon
28
Groupon
GRPN
$1.03B
$367K 0.24%
5,520
INSY
29
DELISTED
Insys Therapeutics, Inc.
INSY
$271K 0.18%
29,409
PLSE icon
30
Pulse Biosciences
PLSE
$2.37B
$229K 0.15%
37,454
WW
31
DELISTED
WW International
WW
$229K 0.15%
+20,000
New +$215K
SCOR icon
32
Comscore
SCOR
$113M
$158K 0.11%
250
ALDR
33
DELISTED
Alder Biopharmaceuticals
ALDR
$104K 0.07%
5,000
TLGT
34
DELISTED
Teligent, Inc
TLGT
$92K 0.06%
1,382
CPIX icon
35
Cumberland Pharmaceuticals
CPIX
$99.8M
$61K 0.04%
10,939
CTIC
36
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$21K 0.01%
5,025
CCLD icon
37
CareCloud
CCLD
$103M
$17K 0.01%
22,903
-40,868
-64% -$35.1K
OTLK icon
38
Outlook Therapeutics
OTLK
$187M
$16K 0.01%
+32
New +$17.9K
SNGX icon
39
Soligenix
SNGX
$5.36M
$3K ﹤0.01%
+4
New +$2.32K
BX icon
40
Blackstone
BX
$104B
-295,009
Closed -$7.53M
FOLD
41
DELISTED
Amicus Therapeutics
FOLD
-20,000
Closed -$148K
PJT icon
42
PJT Partners
PJT
$4.26B
-15,000
Closed -$409K
VANI icon
43
Vivani Medical
VANI
$109M
-354
Closed -$30K
VXRT
44
DELISTED
Vaxart
VXRT
-783
Closed -$17K
ADMS
45
DELISTED
Adamas Pharmaceuticals
ADMS
-30,140
Closed -$495K
AKRX
46
DELISTED
Akorn Inc
AKRX
-57,871
Closed -$1.58M
MON
47
DELISTED
Monsanto Co
MON
-15,100
Closed -$1.54M
CXRX
48
PUT
DELISTED
Concordia International Corp. Common Stock
CXRX
-31
Closed -$2K
PNRA
49
DELISTED
Panera Bread Co
PNRA
-2,400
Closed -$467K
QLTI
50
DELISTED
QLT Inc
QLTI
-1,592,993
Closed -$3.28M

Similar funds

JW Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, JW Asset Management held 50 positions worth $150M, up 3.5% from $145M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

JW Asset Management's Q4 2016 filing shows 10 new, 7 increased, 5 reduced and 11 closed positions. Its largest new stake was Goldman Sachs: 73,064 shares worth $17.5M. The largest sale was Meta Platforms (Facebook), an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Financials and Consumer Discretionary.

  • JW Asset Management's largest Q4 2016 buy was Goldman Sachs: 73,064 shares worth $17.5M.
  • JW Asset Management added most to Alphabet (Google) Class A in Q4 2016, an estimated $2.4M increase.
  • JW Asset Management's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $10.2M.
  • JW Asset Management fully exited Blackstone in Q4 2016, selling an estimated $7.53M.
  • JW Asset Management's ten largest holdings make up 79% of its $150M portfolio in Q4 2016.
  • JW Asset Management opened 10 new positions and closed 11 in Q4 2016.
  • JW Asset Management's portfolio value rose 3.5% quarter-over-quarter to $150M.

Based on JW Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.